Table 1.
p38 Subfamily | Other Names | Upstream | Location/Function | Dysfunction and Diseases |
---|---|---|---|---|
p38α | MAPK14, SAPK2a, CSBP | MKK3, MKK4, MKK6, MKK7 | Ubiquitously expressed at significant levels in most cell types. Involved in the regulation of cell proliferation, differentiation, development, and response to stress [77,78,84,99]. | Defective placental angiogenesis causing embryo death (mouse), symmetric synchronous cell cleavage (zebrafish), reduction in erythropoietin (Epo) production [99], leading to anemia, the impairment of glucogenesis (mice), and lipid-induced insulin-resistance (rat) [77,97]. |
p38β | MAPK 11 | MKK3, MKK4, MKK6 | Ubiquitously expressed; upregulated in the CNS and lungs, downregulated in the healthy heart [104,105,106]. | No phenotype found [77]. |
p38γ | MAPK 13, ERK6, SAPK3 1 | MKK3, MKK4, MKK6MKK7 | Myoblast and skeletal muscle./(1) Under stress conditions, they act on scaffold proteins targeting the plasma membrane cytoskeleton at sites of neuromuscular junctions and gap junctions [107]. (2) Recent studies indicate that the microbial metabolite imidazole propionate may contribute to the pathogenesis of type 2 diabetes via the activation of p38γ/p62/ mTORC1 [89]. |
No phenotype found (mouse) [77]. Meiotic G2/M progression of oocytes (xenopus) [77,104,105]. |
p38δ | MAPK 12, SAPK4 | MKK3, MKK4, MKK6, MKK7 | Only expressed in the lungs, kidney, testis, spleen, pancreas, and small intestine in humans, rats, and mice, but not in other vertebrates; enriched in endocrine glands [107,108]./(1) Regulates cytoplasmic microtubule dynamics, including tau protein [107]. (2) Upregulated in the liver in obese patients with NAFLD [89]. | No phenotype found [77]. |
SAPK: stress-activated protein kinase; CNS: central nervous system; mTORC1: mammalian target of rapamycin complex 1 or mechanistic target of rapamycin complex 1; NAFLD: nonalcoholic fatty liver disease.